SK Life Science, Inc., a U.S. subsidiary of SK Biopharmaceuticals, stands at the forefront of innovation in healthcare. Both companies are proud members of SK Group, a global powerhouse recognized by TIME as one of the World's Best Companies in 2024 and among TIME’s 100 Most Influential Companies in 2023. Headquartered in Paramus, New Jersey, SK Life Science is passionately committed to transforming lives through groundbreaking treatments for central nervous system (CNS) disorders. With an ambitious vision for the future, we are also advancing the fight against cancer, striving to revolutionize oncology care. Driven by innovation, we are dedicated to delivering products that make a meaningful impact on patients' lives, reshaping the landscape of CNS and cancer treatment. At SK Life Science, we see a future where science and compassion converge to redefine possibilities in healthcare. For more information about SK Life Science, please visit https://www.sklifescienceinc.com. View our community guidelines here: bit.ly/447WI1A